This Article Free Full Text (Free PDF) Free All Versions of this Article: 0272989X07306111v1 27/6/772    most recent References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Hernández, R. Articles by Vale, L. Search for Related Content PubMed PubMed Citation Articles by Hernández, R. Articles by Vale, L. Social Bookmarking                         What's this?

The Value of Myocardial Perfusion Scintigraphy in the Diagnosis and Management of Angina and Myocardial Infarction: A Probabilistic Economic Analysis

Health Economics Research Unit, University of Aberdeen, Aberdeen, Scotland, UK, r.a.hernandez @abdn.ac.uk

Luke Vale, PhD

Health Economics Research Unit, University of Aberdeen, Aberdeen, Scotland, UK, Health Services Research Unit, University of Aberdeen, Aberdeen, Scotland, UK

Background and Aim. Coronary heart disease (CHD) is the most common cause of death in the United Kingdom, accounting for more than 120,000 deaths in 2001, among the highest rates in the world. This study reports an economic evaluation of single photon emission computed tomography myocardial perfusion scintigraphy (SPECT) for the diagnosis and management of coronary artery disease (CAD). Methods. Strategies involving SPECT with and without stress electrocardiography (ECG) and coronary angiography (CA) were compared to diagnostic strategies not involving SPECT. The diagnosis decision was modeled with a decision tree model and long-term costs and consequences using a Markov model. Data to populate the models were obtained from a series of systematic reviews. Unlike earlier evaluations, a probabilistic analysis was included to assess the statistical imprecision of the results. The results are presented in terms of incremental cost per quality-adjusted life year (QALY). Results. At prevalence levels of CAD of 10.5%, SPECT-based strategies are cost-effective; ECG-CA is highly unlikely to be optimal. At a ceiling ratio of £20,000 per QALY, SPECT-CA has a 90% likelihood of being optimal. Beyond this threshold, this strategy becomes less likely to be cost-effective. At more than £75,000 per QALY, coronary angiography is most likely to be optimal. For higher levels of prevalence (around 50%) and more than a £10,000 per QALY threshold, coronary angiography is the optimal decision. Conclusions. SPECT-based strategies are likely to be cost-effective when risk of CAD is modest (10.5%). Sensitivity analyses show these strategies dominated non-SPECT-based strategies for risk of CAD up to 4%. At higher levels of prevalence, invasive strategies may become worthwhile. Finally, sensitivity analyses show stress echocardiography as a potentially cost-effective option, and further research to assess the relative cost-effectiveness of echocardiography should also be performed.

Key Words: coronary heart disease • coronary artery disease • cost-utility analyses • probabilistic sensitivity analysis.

This version was published on December 1, 2007

Medical Decision Making, Vol. 27, No. 6, 772-788 (2007)
DOI: 10.1177/0272989X07306111


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				R. Chisin Cost-Effectiveness Analysis J. Nucl. Med., March 1, 2009; 50(3): 338 - 339. [Full Text] [PDF]